Gainers
- ShiftPixy, Inc. (NASDAQ:PIXY) jumped 94.4% to $27.24. ShiftPixy announced a 1-for-100 reverse stock split.
- Hempacco Co., Inc. (NASDAQ:HPCO) shares climbed 63% to $8.33 after dropping 34% on Wednesday. Hempacco's common shares began trading on the Nasdaq Tuesday. The company had planned to offer 1 million shares of common stock at a public offering price of $6 per share for total gross proceeds of $6 million.
- Bright Green Corporation (NASDAQ:BGXX) shares gained 50% to $2.07 after gaining around 33% on Wednesday.
- Forma Therapeutics Holdings, Inc. (NASDAQ:FMTX) rose 48.5% to $19.90 after Novo Nordisk announced it will acquire the company for $20 per share in cash.
- GigaCloud Technology Inc. (NASDAQ:GCT) jumped 45% to $21.20.
- Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA) rose 30.5% to $2.31 after the company announced it has entered into a purchase agreement with Arena Business Solutions for up to $15 million of the company's common stock.
- Shuttle Pharmaceuticals, Inc. (NASDAQ:SHPH) shares jumped 30% to $50.02 amid post-IPO volatility. The company priced its IPO at $8.125 per unit.
- Nutanix, Inc. (NASDAQ:NTNX) jumped 29.8% to $22.45 after the company reported better-than-expected sales results for its fourth quarter and issued strong revenue forecast.
- Bone Biologics Corporation (NASDAQ:BBLG) rose 22% to $1.69.
- Twin Disc, Incorporated (NASDAQ:TWIN) gained 19.6% to $11.12 after the company posted a profit for the fourth quarter.
- Virax Biolabs Group Limited (NASDAQ:VRAX) jumped 18% to $4.14.
- Guardforce AI Co., Limited (NASDAQ:GFAI) gained 17% to $0.4250.
- Golden Sun Education Group Limited (NASDAQ:GSUN) rose 14.6% to $38.77.
- Turquoise Hill Resources Ltd. (NYSE:TRQ) rose 13.8% to $31.26. Rio Tinto Group announced plans to acquire full ownership of Turquoise Hill Resources for C$43 per share in cash.
- InMed Pharmaceuticals Inc. (NASDAQ:INM) gained 13.5% to $0.27. InMed Pharmaceuticals recently announced a 1:25 share consolidation to meet Nasdaq listing criteria.
- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) surged 12% to $28.56. Agios Pharmaceuticals, last month, reported better-than-expected Q2 EPS and sales results.
- RiceBran Technologies (NASDAQ:RIBT) climbed 9.9% to $2.54. The company, last month, posted upbeat quarterly sales.
- Clarus Corporation (NASDAQ:CLAR) gained 9.7% to $16.66. Clarus issued statement on recent stock volatility and Parallax's unauthorized purchases of common stock.
- Belite Bio, Inc (NASDAQ:BLTE) jumped 7.8% to $34.64. Belite Bio recently announced it has commenced enrollment for the US Phase 3 clinical trial of LBS-008 in patients with Stargardt Disease.
- ObsEva SA (NASDAQ:OBSV) rose 6.3% to $0.1909 after declining around 12% on Wednesday.
- Five Below, Inc. (NASDAQ:FIVE) rose 6% to $135.51 after the company reported Q2 earnings results.
